Wholesale distribution isn’t that volatile of a business, but looking at Core-Mark (CORE)
shares, and particularly the overreactions around earnings reports,
you’d think this was a biotech, or at least a popular trading target. In
any case, while the company does appear to be back on track as far as
leveraging its infrastructure and driving better margins go, the share
price isn’t a particular bargain today. Given how these shares have
traded over the last few years, though, it may be worth keeping on a
watchlist so as to buy after another market freak-out.
Click here for more:
Core-Mark Achieving Better Leverage, But Volatility And Valuation Are Issues
No comments:
Post a Comment